Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation

Journal of the American College of Cardiology

Volumn 31, Issue 3, 1998, Pages 637-644

  Lee, Shih Huang ^a   Chen, Shih Ann ^b   Tai, Ching Tai ^a   Chiang, Chern En ^a   Wen, Zu Chi ^a   Cheng, Jun Jack ^b   Ding, Yu An ^a   Chang, Mau Song ^a  

^a Dept of Med and Inst of Clin M ^*  (Taiwan)

^b Shin Kong Memorial Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SYNCOPE; THORAX PAIN; TREATMENT OUTCOME; VERTIGO; VISUAL IMPAIRMENT;

ACTIVITIES OF DAILY LIVING; AGED; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CATHETER ABLATION; CONFOUNDING FACTORS (EPIDEMIOLOGY); ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIONUCLIDE ANGIOGRAPHY; VENTRICULAR FUNCTION, LEFT;

EID: 0032030758     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00530-5     Document Type: Article

References (33)

1. Lemery R, Brugada P, Cheriex E, Wellens HJJ. Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation. Am J Cardiol. 60:1987;1406-1408.
2. Kay GN, Bubien RS, Epstein AE, Plumb VJ. Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation. Am J Cardiol. 62:1988;741-744.
3. Rosenqvist M, Lee MA, Moulinier L, et al. Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction. J Am Coll Cardiol. 15:1990;1467-1474.
4. Heinz G, Siostrzonek P, Kreiner G, Gossinger H. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug-refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol. 69:1992;489-492.
5. Auricchio A, Klein H, Trappe HJ, Salo R. Effect on ventricular performance of direct current electrical shock for catheter ablation of the atrioventricular junction. PACE. 15:1992;344-356.
6. Twidale N, Sutton K, Bartlett L, et al. Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias. PACE. 16:1993;1275-1284.
7. Rodriguez LM, Smeets JLRM, Xie B, et al. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol. 72:1993;1137-1141.
8. Brignole M, Gianfranchi L, Menozzi C, et al. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol. 74:1994;242-246.
9. Fitzpatrick AP, Kourouyan HD, Siw A, et al. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation impact of treatment in paroxysmal and established atrial fibrillation . Am Heart J. 131:1996;499-507.
10. Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 94:1996;1585-1591.
11. Williamson BD, Strickberger SA, Hummel JD, et al. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med. 331:1994;910-917.
12. Feld GK, Fleck RP, Fujimura O, Prothro DL, Bahnson TD, Ibarra M. Control of rapid ventricular response by radiofrequency catheter modification of the AV node in patients with medically refractory atrial fibrillation. Circulation. 90:1994;2299-2307.
13. Blanck Z, Dhala A, Sra J, et al. Characterization of AV nodal behavior and ventricular response during atrial fibrillation before and after a selective slow-pathway ablation. Circulation. 91:1995;1086-1094.
14. Kreiner G, Heinz G, Siostrzonek P, Gossinger HD. Effect of slow pathway ablation on ventricular rate during atrial fibrillation dependence on electrophysiological properties of the fast pathway . Circulation. 93:1996;277-283.
15. Chen SA, Lee SH, Chiang CE, et al. Electrophysiological mechanisms in successful radiofrequency catheter modification of atrioventricular junction for patients with medically refractory paroxysmal atrial fibrillation. Circulation. 93:1996;1690-1701.
16. Chen SA, Chiang CE, Tai CT, et al. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia. Circulation. 93:1996;2023-2032.
17. Lee SH, Chen SA, Wu TJ, et al. Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia. Am J Cardiol. 76:1995;675-678.
18. Starling MR, Crawford MH, Sorensen SG, Levi B, Richards KL, O'Rourke RA. Comparative accuracy of apical biplane cross-sectional echocardiography and gated equilibrium radionuclide angiography for estimating left ventricular size and performance. Circulation. 63:1981;1075-1084.
19. Marshall RC, Berger HJ, Costin JC, et al. Assessment of cardiac performance with quantitative radionuclide angiocardiography sequential left ventricular ejection fraction, normalized left ventricular ejection rate, and regional wall motion . Circulation. 56:1977;820-829.
20. Morady F, Hasse C, Strickberger SA, et al. Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol. 27:1997;113-121.
21. Gomes JAC, Damanto AN, Akhtar M, et al. Ventricular septal motion and left ventricular dimensions during abnormal ventricular activation. Am J Cardiol. 39:1977;641-650.
22. Packer DL, Bardy GH, Worly SJ, et al. Tachycardia-induced cardiomyopathy a reversible form of the left ventricular dysfunction . Am J Cardiol. 57:1986;563-570.
23. Rabbani LE, Wang PJ, Couper GL, Friedman PL. Time course of improvement in ventricular function after ablation of incessant automatic atrial tachycardia. Am Heart J. 121:1991;816-819.
24. Zipes DP, Prystowsky EN, Heger JJ. Amiodarone electrophysiologic actions, pharmacokinetics and clinical effects . J Am Coll Cardiol. 3:1984;1059-1071.
25. Corday E, Gold H, de Vera LB, Williams JH, Fields J. Effect of the cardiac arrhythmias on the coronary circulation. Ann Intern Med. 50:1959;535-553.
26. Coleman HN, Taylor RR, Pool PE, et al. Congestive heart failure following chronic tachycardia. Am Heart J. 81:1971;790-798.
27. Riegger AJG, Liebau G. The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog. Clin Sci. 62:1982;465-469.
28. Armstrong PW, Stopps TP, Ford SE, Bold AJ. Rapid ventricular pacing in the dog pathophysiologic studies of heart failure . Circulation. 74:1986;1075-1084.
29. Rosenqvist M, Isaaz K, Botvinick E, et al. Relative importance of activation sequence compared to AV synchrony in left ventricular function. Am J Cardiol. 67:1991;148-156.
30. Betocchi S, Piscione F, Villari B, et al. Effects of induced asynchrony on left ventricular diastolic function in patients with coronary artery disease. J Am Coll Cardiol. 21:1993;1124-1131.
31. Chorro FJ, Kirchhof HJ, Brugada J, Allessie MA. Ventricular response during irregular atrial pacing and atrial fibrillation. Am J Physiol. 28:1990;H1015-H1021.
32. Daoud EG, Weiss R, Bahu M, et al. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol. 78:1996;1433-1436.
33. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well being of patients with chronic conditions results from the Medical Outcomes Study . JAMA. 262:1989;907-913.